Phase I/II Radiation Dose-Escalation Trial of Intensity Modulated Radiotherapy (IMRT) with Concurrent Fixed Dose-Rate Gemcitabine (FDR-G) for Unresectable Pancreatic Cancer

2011 ◽  
Vol 81 (2) ◽  
pp. S127-S128 ◽  
Author(s):  
E. Ben-Josef ◽  
M. Schipper ◽  
I. Francis ◽  
G. Khan ◽  
S. Hadley ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Radiation Dose ◽  
Phase I ◽  
Dose Rate ◽  
Dose Escalation ◽  
Intensity Modulated Radiotherapy ◽  
Fixed Dose ◽  
Unresectable Pancreatic Cancer ◽  
Intensity Modulated ◽  
Fixed Dose Rate

scholarly journals Phase I Study of Fixed Dose Rate Infusion of Gemcitabine in Patients with Unresectable Pancreatic Cancer

2005 ◽  
Vol 35 (12) ◽  
pp. 733-738 ◽  
Author(s):  
Junji Furuse ◽  
Hiroshi Ishii ◽  
Takuji Okusaka ◽  
Michitaka Nagase ◽  
Kohei Nakachi ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Phase I ◽  
Dose Rate ◽  
Phase I Study ◽  
Fixed Dose ◽  
Unresectable Pancreatic Cancer ◽  
Fixed Dose Rate ◽  
Fixed Dose Rate Infusion ◽  
Rate Infusion

scholarly journals A Phase I–II dose escalation study of fixed-dose rate gemcitabine, oxaliplatin and capecitabine every two weeks in advanced cholangiocarcinomas

2010 ◽  
Vol 50 (3) ◽  
pp. 448-454 ◽  
Author(s):  
Ulrik Lassen ◽  
Lars Henrik Jensen ◽  
Morten Sorensen ◽  
Kristoffer S. Rohrberg ◽  
Zaza Ujmajuridze ◽  
...  
Keyword(s):  
Phase I ◽  
Dose Rate ◽  
Dose Escalation ◽  
Fixed Dose ◽  
Dose Escalation Study ◽  
Fixed Dose Rate
Sign in / Sign up

Export Citation Format

Share Document